Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study

10.1016/S1470-2045(10)70203-5

Saved in:
Bibliographic Details
Main Authors: Bible, K.C., Suman, V.J., Molina, J.R., Smallridge, R.C., Maples, W.J., Menefee, M.E., Rubin, J., Sideras, K., Morris, J.C., McIver, B., Burton, J.K., Webster, K.P., Bieber, C., Traynor, A.M., Flynn, P.J., Goh, B.C., Tang, H., Ivy, S.P., Erlichman, C.
Other Authors: PHARMACOLOGY
Format: Article
Published: 2016
Online Access:http://scholarbank.nus.edu.sg/handle/10635/127090
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-127090
record_format dspace
spelling sg-nus-scholar.10635-1270902023-10-29T22:33:33Z Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study Bible, K.C. Suman, V.J. Molina, J.R. Smallridge, R.C. Maples, W.J. Menefee, M.E. Rubin, J. Sideras, K. Morris, J.C. McIver, B. Burton, J.K. Webster, K.P. Bieber, C. Traynor, A.M. Flynn, P.J. Goh, B.C. Tang, H. Ivy, S.P. Erlichman, C. PHARMACOLOGY 10.1016/S1470-2045(10)70203-5 The Lancet Oncology 11 10 962-972 LOANB 2016-09-07T05:36:36Z 2016-09-07T05:36:36Z 2010-10 Article Bible, K.C., Suman, V.J., Molina, J.R., Smallridge, R.C., Maples, W.J., Menefee, M.E., Rubin, J., Sideras, K., Morris, J.C., McIver, B., Burton, J.K., Webster, K.P., Bieber, C., Traynor, A.M., Flynn, P.J., Goh, B.C., Tang, H., Ivy, S.P., Erlichman, C. (2010-10). Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study. The Lancet Oncology 11 (10) : 962-972. ScholarBank@NUS Repository. https://doi.org/10.1016/S1470-2045(10)70203-5 14702045 http://scholarbank.nus.edu.sg/handle/10635/127090 000283210600022 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1016/S1470-2045(10)70203-5
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Bible, K.C.
Suman, V.J.
Molina, J.R.
Smallridge, R.C.
Maples, W.J.
Menefee, M.E.
Rubin, J.
Sideras, K.
Morris, J.C.
McIver, B.
Burton, J.K.
Webster, K.P.
Bieber, C.
Traynor, A.M.
Flynn, P.J.
Goh, B.C.
Tang, H.
Ivy, S.P.
Erlichman, C.
format Article
author Bible, K.C.
Suman, V.J.
Molina, J.R.
Smallridge, R.C.
Maples, W.J.
Menefee, M.E.
Rubin, J.
Sideras, K.
Morris, J.C.
McIver, B.
Burton, J.K.
Webster, K.P.
Bieber, C.
Traynor, A.M.
Flynn, P.J.
Goh, B.C.
Tang, H.
Ivy, S.P.
Erlichman, C.
spellingShingle Bible, K.C.
Suman, V.J.
Molina, J.R.
Smallridge, R.C.
Maples, W.J.
Menefee, M.E.
Rubin, J.
Sideras, K.
Morris, J.C.
McIver, B.
Burton, J.K.
Webster, K.P.
Bieber, C.
Traynor, A.M.
Flynn, P.J.
Goh, B.C.
Tang, H.
Ivy, S.P.
Erlichman, C.
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
author_sort Bible, K.C.
title Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
title_short Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
title_full Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
title_fullStr Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
title_full_unstemmed Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
title_sort efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
publishDate 2016
url http://scholarbank.nus.edu.sg/handle/10635/127090
_version_ 1781790292331986944